Page last updated: 2024-08-21

2-aminopurine and thymalfasin

2-aminopurine has been researched along with thymalfasin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Airoldi, A; Pinzello, G; Zavaglia, C	1
Hou, J; Sun, J; Wang, Z	1
Au, WS; Fong, DY; Hou, J; Kung, HF; Lam, SK; Lau, GK; Lin, M; Nanji, A; Yuen, ST	1

Reviews

1 review(s) available for 2-aminopurine and thymalfasin

Article	Year
Antiviral therapy of HBV- and HCV-induced liver cirrhosis. Journal of clinical gastroenterology, 2000, Volume: 30, Issue:3 Topics: 2-Aminopurine; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Male; Prognosis; Reverse Transcriptase Inhibitors; Survival Rate; Thymalfasin; Thymosin; Treatment Outcome	2000

Article

Year

Antiviral therapy of HBV- and HCV-induced liver cirrhosis.

Journal of clinical gastroenterology, 2000, Volume: 30, Issue:3

Topics: 2-Aminopurine; Antiviral Agents; Clinical Trials as Topic; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Male; Prognosis; Reverse Transcriptase Inhibitors; Survival Rate; Thymalfasin; Thymosin; Treatment Outcome

2000

Trials

1 trial(s) available for 2-aminopurine and thymalfasin

Article	Year
Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase. Journal of viral hepatitis, 2002, Volume: 9, Issue:4 Topics: 2-Aminopurine; Adjuvants, Immunologic; Adolescent; Adult; Antiviral Agents; Cell Division; Cells, Cultured; Cytokines; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immune Tolerance; Male; Middle Aged; T-Lymphocytes; Thymalfasin; Thymosin; Time Factors	2002

Article

Year

Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.

Journal of viral hepatitis, 2002, Volume: 9, Issue:4

Topics: 2-Aminopurine; Adjuvants, Immunologic; Adolescent; Adult; Antiviral Agents; Cell Division; Cells, Cultured; Cytokines; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immune Tolerance; Male; Middle Aged; T-Lymphocytes; Thymalfasin; Thymosin; Time Factors

2002

Other Studies

1 other study(ies) available for 2-aminopurine and thymalfasin

Article	Year
[B domain mutations in the polymerase gene of hepatitis B virus during combination therapy with thymosin alpha1 and famciclovir in Chinese asymptomatic HBV carriers]. Zhonghua yi xue za zhi, 2000, Volume: 80, Issue:8 Topics: 2-Aminopurine; Adjuvants, Immunologic; Antiviral Agents; Binding Sites; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Famciclovir; Female; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Male; Mutation; Mutation, Missense; Thymalfasin; Thymosin	2000

Article

Year

[B domain mutations in the polymerase gene of hepatitis B virus during combination therapy with thymosin alpha1 and famciclovir in Chinese asymptomatic HBV carriers].

Zhonghua yi xue za zhi, 2000, Volume: 80, Issue:8

Topics: 2-Aminopurine; Adjuvants, Immunologic; Antiviral Agents; Binding Sites; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Famciclovir; Female; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Male; Mutation; Mutation, Missense; Thymalfasin; Thymosin

2000